Health R&D and AI
- Health R&D : Obstacles, Security, Regulation, Slowing down or Enabling?
- Pharmas and Biotech
- AI, Data driven medicine
Health R&D : Obstacles, Security, Regulation, Slowing down or Enabling?
Pharmas and Biotech
Drug Discovery companies leverage AI to find the most effective combinations of drug compounds, reducing the time and capital required in drug discovery.
Precision Medicine - AI focus
- People are all different - age, race, gender, zip-code
AI-driven Genomic Solutions
Startups in this category are using AI for personalized healthcare, genome sequencing, and CRISPR research.
- Decipher Biosciences
Syntekabio - analyzes an individual’s unique genetic map to provide personalized medical treatments. $33m, S.Korea
WuXi NextCode = applies AI and deep learning to genomic analysis. This research is used to improve patient sampling for drug discovery and accelerate cancer research. $455m VC, MA, USA
Drug Discovery - biotechnology
Biotechnology based Drug Discovery startups that are conducting internal R&D to discover new drugs,
BlackThorn Therapeutics - has developed a pipeline of neurobehavioral therapeutics to treat mood and anxiety disorders, autism, and other neurological disorders. VC=$130m, SFO
Recursion Pharmaceuticals - manages a pipeline of drugs for cardiology, neurology, dermatology, hematology, immunology, ophthalmology, and other focus areas. - $236m VC, Salt Lake City
Drug Discovery - SaaS tools
These Drug Discovery companies are pureplay SaaS startups that sell analytics software to pharmaceutical companies.
- Accutar Biotech
- Atomwise - better medicine faster
- Engine biosciences
- Exscientia driven by knowledge
- Finch Therapeutics
- Frontier Medicines
- Notable Labs
- Spring Discovery
Chinese AI for drug discovery
- DIP - chinese
AI, Data driven medicine
Imaging, Radiology and Diagnostics - AI Computer-Aided Detection
This category includes startups using AI software to detect and diagnose diseases at an early stage.
Freenome - uses AI to find patterns in cell-free biomarkers circulating in the blood that could be associated with cancer. $240m VC, SFO
Path.AI - develops AI-driven diagnostic tools to assist pathologists in clinical decision-making and drug discovery. $75m Boston, MA
- EX? Medical Imaging for Everyone
- Zebra Medical Vision
Clinical Trials - Tools
This category includes companies focused on clinical trial management. Building upon more robust datasets, startups in this category help researchers recruit and retain patients, as well as design and manage their studies.
- deep lens - AI pathology platform called VIPER to identify eligible trial candidates at the point of their diagnosis. $17m VC
Health at Scale Technologies
Teckro - provides researchers with a machine learning-driven platform for monitoring trial progress across geographically dispersed teams. Ireland, raised $41m VC
Startups in this category are developing AI-driven privacy solutions for healthcare administrators, such as the secure transfer of patient data.
Datavant - “deidentifies” patient data so that it can be safely packaged and exchanged with healthcare partners. VC $40m
Protenus - healthcare systems with AI-powered auditing, compliance analytics, and security software for patient and clinical trials data. Baltimore, VC=$36m